Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors.
about
Antimigraine drug, zolmitriptan, inhibits high-voltage activated calcium currents in a population of acutely dissociated rat trigeminal sensory neuronsMigraine in the era of precision medicineNitroglycerin-induced nNOS increase in rat trigeminal nucleus caudalis is inhibited by systemic administration of lysine acetylsalicylate but not of sumatriptanMolecular cloning, pharmacological properties and tissue distribution of the porcine 5-HT(1B) receptorNaratriptan: an alternative for migraine.Current and emerging second-generation triptans in acute migraine therapy: a comparative review.Meningeal nociception: electrophysiological studies related to headache and referred pain.Eletriptan.The antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain.The discovery of a new drug class for the acute treatment of migraine.Finding new drug targets for the treatment of migraine attacks.Migraine pathophysiology.Naratriptan: a review.Does sumatriptan cross the blood-brain barrier in animals and man?Neuropeptide Y inhibits the trigeminovascular pathway through NPY Y1 receptor: implications for migraine.Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and "triptan" receptors: implications in migraine.The blood-brain barrier in migraine treatment.Chemical mediators of migraine: preclinical and clinical observations.Insights into the pharmacological targeting of the trigeminocervical complex in the context of treatments of migraine.Efficacy and mechanism of anticonvulsant drugs in migraine.Pathophysiology of Migraine: A Disorder of Sensory Processing.Spinal trigeminal neurons demonstrate an increase in responses to dural electrical stimulation in the orofacial formalin test.Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B/1D agonist.TRPV1 receptor blockade is ineffective in different in vivo models of migraine.Neurophysiological markers of central sensitisation in the trigeminal pathway and their modulation by the cyclo-oxygenase inhibitor ketorolac.Migraine recurrence is not associated with depressive or anxiety symptoms. Results of a randomized controlled trial.Persistence of attacks of cluster headache after trigeminal nerve root section.Effects of donitriptan on carotid haemodynamics and cardiac output distribution in anaesthetized pigs.Effect of the adenosine A1 receptor agonist GR79236 on trigeminal nociception with blink reflex recordings in healthy human subjects.Naratriptan has a selective inhibitory effect on trigeminovascular neurones at central 5-HT1A and 5-HT(1B/1D) receptors in the cat: implications for migraine therapy.Targeting the central projection of the dural trigeminovascular system for migraine prophylaxis.Intravenous dextromethorphan/quinidine inhibits activity of dura-sensitive spinal trigeminal neurons in rats.EHMTI-0034. Pharmacological modulation of trigemino-nociceptive stimulation pd06.Serotonin infusions inhibit sensory input from the dural vasculature.
P2860
Q21093203-1A17DE18-F598-41F1-9E8E-C634459E611BQ26748947-494B9726-8B3D-427B-A4CF-A65D0BD4FDA5Q28168693-F0EE3B12-9364-4E6A-900F-9F3FECCB7AF8Q28343925-581A9465-C05F-48CB-B08E-795645FCDB08Q33689204-356D8975-1B52-4642-87B7-09650CF4A3D9Q33908453-6020D063-33EE-4308-91C3-CE8811ABB977Q34218294-181B7A68-E908-4618-93D7-2D0FE9A87184Q34481786-6E77106E-58B0-46C0-8409-C6E174E234DBQ34529520-6A78C0D1-6BD8-4EBD-8481-8105CF8C5476Q34617817-B93DD685-D9C1-4B2D-917A-997E1CB8EFECQ34954050-C3B723C2-17C2-4DF3-8FDC-CF4D6AF003BCQ36099504-497F4377-10A4-4C5B-A7E5-C6C73940B237Q36181337-B0390E99-7ED9-4F7B-A602-2FBFE953736CQ36260908-55ED75A4-8E3B-4815-9321-8EA8B636AD3BQ37104106-2C69F895-9489-4A81-AFD5-28D90B13499CQ37165496-DF7B7869-2B83-48F9-ADAF-2FA82083D518Q37252452-4AE2E8AE-382C-45C0-BECC-9EBBC5D60746Q37883455-B77F57F9-7421-47FB-8CDF-50243F0E3947Q38129436-3A75BE9F-42AD-404A-83E8-3AF5646EA3E1Q38185096-AD149D38-88D7-4D93-84D9-ACCF7CD0C9BAQ39127073-263275AB-59F0-41AD-9077-928F35EE5448Q40224193-6FBF3EA0-79F3-4F60-A098-36E75763E910Q42572987-2573BB79-1FDD-4B5D-9F80-24529D1823BFQ42679624-CB3D5DC4-961A-4743-AF9C-DA5603E4A2D0Q42882632-08B68E8C-E5C1-4D1C-8783-F90B3328BC5CQ43050704-61D756AC-31BE-4668-BD14-B95BEF7AAC4BQ43964370-7512D0BD-7621-44D1-A65C-E2C6BE355A2FQ43981823-7537AF5A-AF9C-4F36-99DD-9E324BD6D04DQ44418453-4B9D2F34-964E-4E25-A92A-E047DC1F8645Q44731908-F28674D8-B89C-4187-B504-24C082D73374Q46165982-7BC75081-886F-4FD6-9C06-24C9836A070EQ46550880-26C0F71A-0304-4A8D-80A2-198825A1DBEBQ46807178-50349DA6-54BF-4633-A90C-C44187F2A59AQ48089050-EEAD3178-20E6-4CEC-81A8-A90FAF60D2D9
P2860
Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors.
description
1997 nî lūn-bûn
@nan
1997 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Inhibition of trigeminal neuro ...... amine (5-HT(1B/1D)) receptors.
@ast
Inhibition of trigeminal neuro ...... amine (5-HT(1B/1D)) receptors.
@en
type
label
Inhibition of trigeminal neuro ...... amine (5-HT(1B/1D)) receptors.
@ast
Inhibition of trigeminal neuro ...... amine (5-HT(1B/1D)) receptors.
@en
prefLabel
Inhibition of trigeminal neuro ...... amine (5-HT(1B/1D)) receptors.
@ast
Inhibition of trigeminal neuro ...... amine (5-HT(1B/1D)) receptors.
@en
P356
P1476
Inhibition of trigeminal neuro ...... amine (5-HT(1B/1D)) receptors.
@en
P2093
P2860
P304
P356
10.1038/SJ.BJP.0701456
P407
P577
1997-11-01T00:00:00Z